InspireMD (NSPR) Assets Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | InspireMD | 64.01 Mn | 9.80 Mn | 1.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 31.31% |
| Sep 30, 2025 | 38.12% |
| Jun 30, 2025 | 13.45% |
| Mar 31, 2025 | 39.25% |
| Dec 31, 2024 | 36.49% |
| Sep 30, 2024 | 34.14% |
| Jun 30, 2024 | 43.07% |
| Mar 31, 2024 | 33.11% |
| Dec 31, 2023 | 31.13% |
| Sep 30, 2023 | 29.13% |
| Jun 30, 2023 | 41.45% |
| Mar 31, 2023 | 22.29% |
| Dec 31, 2022 | 32.19% |
| Sep 30, 2022 | 31.59% |
| Jun 30, 2022 | 29.76% |
| Mar 31, 2022 | 27.32% |
| Dec 31, 2021 | 33.37% |
| Sep 30, 2021 | 27.88% |
| Jun 30, 2021 | 72.69% |
| Dec 31, 2020 | 25.58% |
| Jun 30, 2020 | 5.52% |
| Dec 31, 2019 | -2.92% |
| Jun 30, 2019 | -7.83% |
| Mar 31, 2019 | -12.41% |
| Dec 31, 2018 | -12.51% |
| Sep 30, 2018 | -4.66% |
| Jun 30, 2018 | -14.51% |
| Mar 31, 2018 | -5.75% |
| Dec 31, 2017 | -12.04% |
| Sep 30, 2017 | -12.18% |
| Jun 30, 2017 | -11.07% |
| Mar 31, 2017 | 4.27% |
| Dec 31, 2016 | -2.10% |
| Sep 30, 2016 | 0.63% |
| Jun 30, 2016 | -23.25% |
| Dec 31, 2015 | 5.50% |